MAGI-2 Inhibits cell migration and proliferation via PTEN in human hepatocarcinoma cells

MAGI-2, a multidomain scaffolding protein, contains nine potential protein–protein interaction modules, including a GuK domain, two WW domains and six PDZ domains. In this study, we examined eight human hepatocarcinoma cell lines (HHCCs) and found that MAGI-2 was expressed only in 7721 cells. After...

Full description

Saved in:
Bibliographic Details
Published inArchives of biochemistry and biophysics Vol. 467; no. 1; pp. 1 - 9
Main Authors Hu, Yali, Li, Zengxia, Guo, Liang, Wang, Liying, Zhang, Lineng, Cai, Xiumei, Zhao, Hongbo, Zha, Xiliang
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.11.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:MAGI-2, a multidomain scaffolding protein, contains nine potential protein–protein interaction modules, including a GuK domain, two WW domains and six PDZ domains. In this study, we examined eight human hepatocarcinoma cell lines (HHCCs) and found that MAGI-2 was expressed only in 7721 cells. After 7721, 7404 and 97H cells were transfected with myc-MAGI-2 plasmid, their migration and proliferation was significantly inhibited, which was associated with downregulation of p-FAK and p-Akt. It is known that p-FAK is a substrate of PTEN and p-Akt can be regulated by PTEN via PIP3. We demonstrated that PTEN was upregulated after myc-MAGI-2 transfection, which was due to the enhancement of PTEN protein stability rather than mRNA levels. Furthermore, MAGI-2-induced inhibition of cell migration and proliferation was attenuated in 7721 cells with PTEN silence or in PTEN-null cell line U87MG, and PTEN transfection could restore the effect of MAGI-2 in U87MG cells. Finally, the molecular association between PTEN and MAGI-2 was confirmed. Our results suggested that PTEN played a critical role in MAGI-2-induced inhibition of cell migration and proliferation in HHCCs.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0003-9861
1096-0384
DOI:10.1016/j.abb.2007.07.027